The New Face of M&A in the Life Sciences Industry

Boston
25 July 2018 - 27 July 2018
Hosted By: American Conference Institute

The complexion of mergers in the life sciences industry has evolved significantly in recent years. No longer can the legal community exclusively think of pharma to pharma mergers. Today, life sciences companies merge with or are purchased by tech companies, biotech firms, and even retailers. NERA Managing Director Dr. Christine Meyer will join a group of leading women life sciences lawyers on panel that will address the far-reaching impacts of these transactions and the common issues attorneys face when working with companies unfamiliar to the challenges of complying with life sciences regulations.

The presentation will be held at the Women Leaders in Life Sciences Law conference, an annual event that enables women life sciences practitioners to discuss the challenges and opportunities facing women in this industry and to learn about new legal developments for pharmaceutical, biotech, and medical device companies in the life sciences world. NERA is a proud sponsor of the 2018 conference.

For details and to register, please visit the conference website.

To contact us about this event, please click here.